Liat Hayardeny
Company: Galmed Pharmaceuticals
Job title: Chief Scientific Officer
Seminars:
Exploring Aramchol – Lessons Learned & Optimization Towards Registrational Part of Phase 3 Clinical Study 2:30 pm
• Explaining liver fibrosis – from basic pathophysiology to mechanism of action of drug candidates. • Targeting liver fibrosis: Understanding its main challenges. • Aramchol 101: Discovering its mechanism of action, compound optimization, and resulting clinical efficacy.Read more
day: Day 1 Stream 3 PM